Welcome to the Pharmacy News homepage. You are browsing the most recent 35 articles. Visit the archive with all our Pharmacy articles.
Multi-drug resistant (MDR) infections are a serious problem in heathcare, causing 25,000 deaths per year in the European...
According to the National Migraine Centre, one in seven people around the globe are affected by migraines, making...
The NHS has made a new offer to a drug company to provide medicine for potentially thousands of cystic fibrosis...
Spinal muscular atrophy (SMA) is a rare genetic disease that up until now has had no treatment for the underlying...
Primary progressive multiple sclerosis (PPMS) is a rare form of MS that affects less than 15 per cent of people...
Irritable bowel syndrome (IBS) is an unpleasant condition for sufferers, leading to cramps, bloating and digestive...
The National Institute for Health and Care Excellence (NICE) has recommended that durvalumab, a new drug, be available...
The National Institute for Health and Care Excellence (NICE) has released a summary of the guidance health professionals...
A new treatment for lung cancer has been approved by the National Institute for Health and Care Excellence (NICE),...
A new recommendation has been issued by the National Institute of Care and Health Excellence (NICE) for the treatment...
A spike in the difficulty of sourcing a range of common medicines could leave many patients facing significant...
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called for concerted action to ensure...
The National Institute of Health and Clinical excellence (NICE) has recommended that a third biological treatment...
It remains to be seen whether the UK will leave the EU with a deal in place in March, but it appears the pharmaceutical...
Pembrolizumab, an immunotherapy drug also known as Keytruda, has been made available to thousands of lung cancer...
The National Institute of Health and Clinical Excellence (NICE) has given its approval to a drug that will help...
The National Institute for Health and Clinical excellence (NICE) has recommended the use of the skin cancer drug...
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment for young sufferers...
A no-deal Brexit may force the public to stockpile medicines, pharmaceutical industry leaders have told MPs.Speaking...
Pharmaceutical firm Novartis is joining Bayer in appealing against a ruling that went in favour of 12 NHS clinical...
The expected impact of a no-deal Brexit on pharmaceutical supplies in the UK after March 29th next year could be much...
NHS pharmacists will be able to go on prescribing a drug for an eye condition at a lower cost to the health service,...
A new melanoma drug cocktail has been approved for use on the NHS by the National Institute for Health and Clinical...
The European Medicines Agency (EMA) has stopped appointing members of the UK’s Medicines and Healthcare Products...
The government has issued the pharmaceutical industry with two letters providing guidance on how to deal with the situation...
The National Institute for Clinical Excellence (NICE) and Public Health England (PHE) have published new guidelines...
Drug manufacturers Sanofi and Novartis have confirmed they are stockpiling medicines in case of a no-deal Brexit. With...
The first new malaria drug to be licensed in the United States in 60 years has been hailed as a major breakthrough...
The National Institute for Health and Care Excellence (NICE) has recommended the drug alectinib for use on the NHS as a treatment...
The National Institute for Health and Care Excellence (NICE) has approved a new therapy for the treatment of multiple...
A clinically-proven therapy for plaque psoriasis has been recommended for NHS use in England, Wales and Scotland.The...